Literature DB >> 22202052

Multiple roles of RBM4 in muscle cell differentiation.

Jung-Chun Lin1, Woan-Yuh Tarn.   

Abstract

Muscle cell differentiation involves gene regulation at both transcriptional and post-transcriptional steps. Post-transcriptional control requires various RNA binding proteins. The multi-functional RNA binding motif 4 (RBM4) protein participates in both precursor mRNA splicing regulation and translational control in muscle cells. In myoblasts, RBM4 promotes the expression of many muscle-specific mRNAs from individual genes via its activity in modulating alternative splicing. In addition, RBM4 transiently translocates to the cytoplasm during myogenesis, where it participates in translation control. RBM4 may act in conjunction with a subset of muscle-specific microRNAs to modulate their activity in translation suppression. Overexpression of RBM4 promotes muscle cell differentiation, suggesting that RBM4 acts as a positive myogenic regulator. In this review, we discuss recent data regarding how RBM4.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22202052     DOI: 10.2741/260

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  10 in total

Review 1.  Regulation of β-cell function by RNA-binding proteins.

Authors:  Maria Grazia Magro; Michele Solimena
Journal:  Mol Metab       Date:  2013-09-25       Impact factor: 7.422

2.  RBM4 modulates the proliferation and expression of inflammatory factors via the alternative splicing of regulatory factors in HeLa cells.

Authors:  Wei-Yang Wang; Weili Quan; Fan Yang; Ya-Xun Wei; Jia-Jun Chen; Han Yu; Jie Xie; Yi Zhang; Zhan-Fei Li
Journal:  Mol Genet Genomics       Date:  2019-09-05       Impact factor: 3.291

3.  RBM4 promotes pancreas cell differentiation and insulin expression.

Authors:  Jung-Chun Lin; Yu-Ting Yan; Wen-Kou Hsieh; Pey-Jey Peng; Chun-Hao Su; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2012-11-05       Impact factor: 4.272

Review 4.  Insulin Receptor Isoforms in Physiology and Disease: An Updated View.

Authors:  Antonino Belfiore; Roberta Malaguarnera; Veronica Vella; Michael C Lawrence; Laura Sciacca; Francesco Frasca; Andrea Morrione; Riccardo Vigneri
Journal:  Endocr Rev       Date:  2017-10-01       Impact factor: 19.871

5.  Alanine repeats influence protein localization in splicing speckles and paraspeckles.

Authors:  Shuo-Hsiu Chang; Wei-Lun Chang; Chia-Chen Lu; Woan-Yuh Tarn
Journal:  Nucleic Acids Res       Date:  2014-11-20       Impact factor: 16.971

6.  Prognostic value of decreased expression of RBM4 in human gastric cancer.

Authors:  Hongmei Yong; Huijun Zhu; Shu Zhang; Wei Zhao; Wei Wang; Chen Chen; Guipeng Ding; Lun Zhu; Ziyuan Zhu; Huaidong Liu; Yongjie Zhang; Jinbo Wen; Xing Kang; Jin Zhu; Zhenqing Feng; Baorui Liu
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

Review 7.  RBM22, a Key Player of Pre-mRNA Splicing and Gene Expression Regulation, Is Altered in Cancer.

Authors:  Benoît Soubise; Yan Jiang; Nathalie Douet-Guilbert; Marie-Bérengère Troadec
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

8.  Phylogenetic and molecular characterization of the splicing factor RBM4.

Authors:  Chia-Chen Lu; Tz-Hao Chen; Jhe-Rong Wu; Hung-Hsi Chen; Hsin-Yi Yu; Woan-Yuh Tarn
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

9.  Rbm24a and Rbm24b are required for normal somitogenesis.

Authors:  Samantha Maragh; Ronald A Miller; Seneca L Bessling; Guangliang Wang; Paul W Hook; Andrew S McCallion
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

10.  Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation.

Authors:  Eugénie Ansseau; Jocelyn O Eidahl; Céline Lancelot; Alexandra Tassin; Christel Matteotti; Cassandre Yip; Jian Liu; Baptiste Leroy; Céline Hubeau; Cécile Gerbaux; Samuel Cloet; Armelle Wauters; Sabrina Zorbo; Pierre Meyer; Isabelle Pirson; Dalila Laoudj-Chenivesse; Ruddy Wattiez; Scott Q Harper; Alexandra Belayew; Frédérique Coppée
Journal:  PLoS One       Date:  2016-01-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.